ALC:NYSE
Alcon AG
$69.83
arrow_upward
+0.61%(+0.42) 1D
$69.50
arrow_downward
-0.47% (-0.33)bedtimeAfter hours
Closed: Oct 28, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$68.88
High
$70.08
Low
$68.82
Mkt. cap
28.87B
Avg. vol.
1.76M
Volume
1.09M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
Open
$68.88
High
$70.08
Low
$68.82
Mkt. cap
28.87B
Avg. vol.
1.76M
Volume
1.09M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
www.marketscreener.com
·
1 hour ago
S&P 500 index showed little change after Stockholm's close
Yahoo Finance
·
24 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga
·
54 minutes ago
Dow Gains For Third Session Following Fed Decision: Investor Sentiment Improves, Greed Index Remains In
Fund Selector Asia
·
2 hours ago
5 healthcare funds outpacing the S&P 500 in 2026
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com